1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > 2015 Strategic Assessments of Current and Emerging Transfusion Diagnostics Market Players

This new report from VPGMarketResearch.com provides extensive analyses of major current and emerging suppliers of transfusion diagnostic instruments and reagents. The assessments include:
  • Sales
  • Product portfolios
  • Marketing tactics
  • Technological know-how
  • New products in R&D
  • Collaborative arrangements
  • Business strategies

Contains 50 pages

This new report from VPGMarketResearch.com provides extensive analyses of major current and emerging suppliers of transfusion diagnostic instruments and reagents. The assessments include:
  • Sales
  • Product portfolios
  • Marketing tactics
  • Technological know-how
  • New products in R&D
  • Collaborative arrangements
  • Business strategies.

    Table Of Contents

    2015 Strategic Assessments of Current and Emerging Transfusion Diagnostics Market Players
    LEADING TRANSFUSION TESTING MARKET KEY PLAYERS
    Strategic Assessments of Major Suppliers
    and Emerging Market Entrants


    - Abbott
    - Beckman Coulter/Danaher
    - Becton Dickinson
    - Biokit
    - BioMerieux
    - Bio-Rad
    - CellMark Forensics/LabCorp
    - Diagast
    - DiaSorin
    - Fujirebio
    - Grifols
    - Hologic/Gen-Probe
    - Immucor
    - Ortho-Clinical Diagnostic
    - Proteome Sciences
    - Quest
    - Quidel
    - Roche
    - Siemens
    - Tecan
    - Thermo Fisher/Life Technologies

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review,  Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Cancer Diagnostics 2017-2021: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Cancer Diagnostics 2017-2021: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 21100
  • Industry report
  • December 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. The report is available by country, section, market segment, and can be custom-tailored to your specific information ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.